Phase 2 Type 2 Diabetes Trial, Recruiting NCT07109700 Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Phase 2 Type 2 Diabetes Trial, Recruiting

NCT07109700
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Type 2 Diabetes for at least 6 months (24 weeks)
  • Your HbA1c blood sugar control reading is between 7.5% and 10.5% (a measure of average blood sugar over the past few months)
  • Your Body Mass Index (BMI) — a measure of body weight relative to height — is between 22.5 and 40.0

Who may not be able to join:

  • You have a type of diabetes other than Type 2 Diabetes
  • You had a serious diabetes-related emergency (such as diabetic ketoacidosis, lactic acidosis, or a dangerous high blood sugar crisis) in the past 6 months
  • You have had a severe low blood sugar episode, or any low blood sugar episodes without warning symptoms, in the past 6 months
  • You have a personal or family history of a specific type of thyroid cancer (medullary thyroid carcinoma), thyroid C-cell overgrowth, or a condition called multiple endocrine neoplasia type 2
  • You have a history of pancreas inflammation (pancreatitis), risk factors for it, or had a symptomatic gallbladder problem in the past 6 months
  • The trial doctor has determined that you have a condition affecting how your stomach empties or absorbs food — such as previous weight-loss surgery, stomach removal surgery, irritable bowel syndrome, persistent indigestion, or delayed stomach emptying (confirm with trial site)
  • You have used any diabetes medications in the past 3 months
  • Your blood hemoglobin level (a measure of red blood cells) is too low — below 100 g/L if you are female, or below 110 g/L if you are male
  • Your fasting blood sugar level is 13.9 mmol/L or higher
  • Your liver enzyme levels (AST and/or ALT) are more than 2.5 times higher than the normal upper limit
  • Your total bilirubin level (related to liver function) is more than 1.5 times higher than the normal upper limit
  • Your fasting triglyceride level (a type of fat in the blood) is above 5.6 mmol/L (500 mg/dL)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +86 18301051549

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Registry
ClinicalTrials.gov
Start date
30 April 2025
Est. completion
31 January 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change from baseline in Hemoglobin A1c (HbA1c)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov